Related Experiment Video
Updated: Oct 9, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid
S H Park1, M C Birchenall-Roberts, Y Yi
1Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892-5055, USA.
Abstract:
Transforming growth factor (TGF)-beta1 plays an important role during hematopoiesis. Previously, we had shown that the growth of a v-Src-transformed myeloid cell line was markedly more inhibited by TGF-beta treatment when compared with the wild-type myeloid cell line. To investigate the increased growth sensitivity of the v-Src-transformed myeloid cell line, 32D-src, to TGF-beta, we examined expression of the TGF-beta type II receptor (TGF-beta RII) gene in myeloid cell lines. Northem blot analysis showed that expression of approximately 8- and 6-kb species of TGF-beta RII transcripts was markedly increased in the 32D-src cell line. The expression of the TGF-beta RII promoter linked to a reporter gene was increased 23-fold by v-Src. DNA transfection and electrophoretic mobility shift assay revealed that v-Src induces TGF-beta RII promoter activity through an AP1/ATF2-like sequence (-219 to -172), ETS binding sites (+1 to +36), and the inverted CCAAT box (-81 to -77). Novel DNA-protein complexes with ETS binding sites are significantly increased in v-src-transformed cell lines compared with the control cell line. These results suggest that v-Src induces activity of the TGF-beta RII promoter through multiple elements by inducing expression of nuclear proteins interacting with these elements.
Insights
v-Src transformation increases sensitivity to transforming growth factor (TGF)-beta1 by upregulating the TGF-beta type II receptor (TGF-beta RII) gene. This involves v-Src activating specific promoter elements, enhancing TGF-beta RII expression in myeloid cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Hematopoiesis
Background:
- Transforming growth factor (TGF)-beta1 is crucial for hematopoiesis.
- v-Src-transformed myeloid cells exhibit heightened sensitivity to TGF-beta1 inhibition compared to wild-type cells.
Purpose of the Study:
- To investigate the molecular mechanisms behind the increased TGF-beta1 sensitivity in v-Src-transformed myeloid cells.
- To examine the role of the TGF-beta type II receptor (TGF-beta RII) gene expression.
Main Methods:
- Northern blot analysis to assess TGF-beta RII transcript levels.
- Reporter gene assays to measure TGF-beta RII promoter activity.
- DNA transfection and electrophoretic mobility shift assays to identify transcription factor binding sites.
Main Results:
- v-Src significantly increased TGF-beta RII transcript expression (8- and 6-kb species) in myeloid cell lines.
- v-Src induced TGF-beta RII promoter activity by 23-fold.
- v-Src activates the TGF-beta RII promoter via AP1/ATF2-like, ETS, and inverted CCAAT elements, increasing specific DNA-protein complex formation.
Conclusions:
- v-Src oncogene upregulates TGF-beta RII gene expression.
- v-Src enhances TGF-beta RII promoter activity through multiple regulatory elements.
- These findings elucidate a mechanism for increased TGF-beta sensitivity in v-Src-transformed cells.
Related Concept Videos
TGF - β Signaling Pathway
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
MAPK Signaling Cascades

